Dialysis is a miracle—but have we begun to take it for granted?
This episode challenges us to rethink how dialysis has shaped nephrology’s priorities, innovation, and identity.
🎧 bit.ly/3DamjQ9
#KidneyCommute #Dialysis #Medical #Nephrology
@sinnefro.bsky.social
Official account of Italian Society of Nephrology - Account ufficiale della Società Italiana di Nefrologia (SIN)
Dialysis is a miracle—but have we begun to take it for granted?
This episode challenges us to rethink how dialysis has shaped nephrology’s priorities, innovation, and identity.
🎧 bit.ly/3DamjQ9
#KidneyCommute #Dialysis #Medical #Nephrology
Simultaneous initiation of finerenone and empagliflozin was effective and well tolerated among CONFIDENCE study participants from Asia, consistent with the overall population ca. 2026 from @asnpublications.bsky.social
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/40965042/
Classic Fred Luft #Nephrology 101 editorial on a study testing the effect of potassium supplement on natriuresis: Eliminating sodium with potassium 🔗 academic.oup.com/ndt/article/... #NephSky #MedSky 🧪
03.02.2026 20:25 — 👍 7 🔁 6 💬 1 📌 0Targeting B cells in IgA nephropathy: from pathogenic insight to therapeutic horizon
doi.org/10.1093/ckj/...
Risk-based referral model to nephrologist specialist care in Stockholm
doi.org/10.1093/ndt/...
scott brimble
#NephGR tomorrow!
@sbrimble.bsky.social on TMA in cancer and the St Joe’s Hamilton onconephrology program
#NephSky
In a #ASNCJASN Kidney Cross-Talk, authors explore recent evidence on Lipoprotein(a) and chronic kidney disease (CKD). Read more: kidney.pub/CJASN0968 Bob Roshanravan
19.01.2026 19:00 — 👍 2 🔁 2 💬 0 📌 0CKD for the Primary Care Provider ca. 2026
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/41152063/
🔬 New Data Deserves a Platform! The Late-Breaking Abstract Call for SCM26 is open.
📌 Must include results from major clinical trials or epidemiological studies to be considered for review.
Learn More: bit.ly/47TaBq4
#Nephrology #MedEd #NKFClinicals #NephSky
Environmental Impacts of Kidney Replacement Therapies: A Comparative Lifecycle Assessment
bit.ly/3KNKibh #OpenAccess
The January issue of Kidney News is now online! Topics this month include:
⦁ A special section on Kidney Watch 2026, top areas to watch this year in nephrology
⦁ The ASN President's Update and new strategic plan
Explore the issue: kidney.pub/KN1801-01 #ASNKidneyNews Kenar Jhaveri, MD
The Italian Society of Nephrology expresses its deep sorrow for the passing of Prof. Claudio Ponticelli, a pioneer in nephrology and an outstanding scientist and mentor. Our heartfelt condolences to his family and colleagues. #RIP #Nephrology
02.01.2026 12:11 — 👍 4 🔁 2 💬 0 📌 0Erectile dysfunction is prevalent among patients with CKD. Read about the mechanisms and treatments at this intersection in #ASNKidneyNews kidney.pub/KN1712-14
Breakdown of solved cases by gene category. Breakdown of the solved uKF cases by gene and phenotypic category. All percentages represent a proportion of the total solved cases (n=38). ADTKD, autosomal dominant tubulointerstitial kidney disease; CAKUT, congenital anomalies of the kidneys and urinary tract.
Quantifying APOL1, Human Leukocyte Antigen, and Other Genetic Contributions to Unexplained Kidney Failure #OpenAccess
bit.ly/4nfGoXe
#CKDs at the Crossroads: From Failures to #Future #Therapies
https://doi.org/10.1016/j.ekir.2025.09.050
#KIRReview
📣Calling all #ResidentDoctors & #MedicalStudents! Thinking about a career in #Nephrology? join our taster event!
Hear from renal registrars & consultants, learn about key conditions, explore career pathways & get tips for CVs & interviews.
👉https://ow.ly/YXRr50XyH0y
#RenalMedicine #KidneyCare
NEW on #AJKDBlog:
AJKDBlog’s Interviews Editor, Timothy Yau chatted with Kristen L. Nowak and Michel Chonchol about the complicated interplay between CKD and systemic inflammation, and new targets/pathways that could improve kidney and cardiovascular outcomes.
bit.ly/4o63tv6 (FREE)
𝗜𝗡𝗦𝗜𝗚𝗛𝗧 is out! 🌍
✨WCN’26 joint sessions
✨ New onconephrology case
✨ ISN Journal summaries on APOL1 kidney disease and expanding peritoneal dialysis in India
✨ New language of Kidney Health Quiz (Swahili) and ISN SGLT2i Toolkit (German and Spanish)
and more! ➡️http://lite.spr.ly/6...
#UrinarySediment from a pt with #AKI #RPGN due to suspected MPO-AAV-GN inspected with Sternheimer stain: WBC cast (bright field), broad RBC cast (bright), waxy cast (bright), and granular cast w/Ca Oxalate monohydrate crystals (oblique). #OchsnerNephrology #UrineMicroscopy
22.11.2025 21:31 — 👍 7 🔁 4 💬 0 📌 0Explores practical strategies for nutrition care in older adults with CKD. Learn how to integrate medical nutrition therapy with geriatric care using the 5 M’s framework and support individualized approaches for complex patients.
📚
Cardio-renoprotective effects of SGLT2 inhibitors—the role of anaemia correction
doi.org/10.1093/ndt/...
⚠ @kireports.bsky.social November issue is out!
Read the latest news in research, highlights from current literature, comprehensive reviews, and in-depth case studies.
www.kireports.org/cu...
#ThisIsISN #Nephrology #Journal #Research #KidneyCommunity #Kidney #OpenAccess
The November 2025 issue is available now! Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/3X1XpZj
The recording of our joint webinar with @theisn.org: "What's New in Patient Training", focused on the recently published Position Paper on Teaching #PeritonealDialysis to Patients and Caregivers, is already available on our Youtube channel:
buff.ly/P2N0NGV
program for thursday at kidney wk including 2 LBCTs and Vlado P talking on RCTs and curing kidney disease
The opening plenary at #KidneyWk looks phenomenal
Renal RCT Renaissance is upon us
(LBCT list drops tomorrow)
www.asn-online.org/education/ki...
The Mayo Imaging Classification of ADPKD description (left panel) and imaging examples (right panel) with examples (right panel) of (a, b) subclass 1A and 1E, (c-f) subclass 2A, and (g, h) subclass 2B. Abbreviations: ADPKD, autosomal dominant polycystic kidney disease; TKV, total kidney volume. Reproduced with permission of the copyright holder (Kidney Disease: Improving Global Outcomes) from Kidney Disease: Improving Global Outcomes (KDIGO) ADPKD Work Group. KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Kidney Int. 2025;107(suppl 2S):S1-S239. doi:10.1016/j.kint.2024.07.009
Core Curriculum by Craig E. Gordon et al:
Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2025
bit.ly/465twwK (FREE)
Excellent thread below
I will also plug this talk by Paola Romagnani on podocytopathies
youtu.be/bRMeqaGgA9I?...
#GlomCon #NephGR